Form 4 for TDOC Teladoc Health, Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0002036989-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-03 | 2025-12-01 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | — | +9,535 | 64.6K | +17% | — |
| D | 2025-12-03 | 2025-12-02 | TDOC | Bliss Kelly | Pres, U.S. Group Health | S - Sale+OE | $7.49 | -4,582 | 60.1K | -7% | -$34.3K |
| DM | 2025-12-03 | 2025-12-01 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | $0.00 | -9,535 | 1,186 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | M | A | 3,488 | — | 59,778 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-12-01 | M | A | 1,189 | — | 56,290 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2025-12-01 | M | A | 4,858 | — | 64,636 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2025-12-02 | S | D | 4,582 | $7.49 | 60,054 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 5 | Derivative | Restricted Stock Units | 2025-12-01 | M | D | 4,858 | $0.00 | 24,293 | D | — · — to — | 4,858 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| 6 | Derivative | Restricted Stock Units | 2025-12-01 | M | D | 3,488 | $0.00 | 3,488 | D | — · — to — | 3,488 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Performance Stock Units | 2025-12-01 | M | D | 1,189 | $0.00 | 1,186 | D | — · — to — | 1,189 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |